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Background: The currently accepted theory, that the human liver store of folate is limited to about four months, is
based on the findings of Victor Herbert and others of the era before folate fortification of food. A recent model,
developed by Lin et al., predicts far greater liver folate storage capacity than reported by Herbert. The conflict
between Herbert’s and Lin’s models needs to be resolved experimentally, however current research is restricted
because ethical considerations prevent such risky experimentation on patients or healthy human volunteers. The
objective was to provide a detailed record of the biochemical and haematological responses to the development
of severe experimental folate deficiency in an initially replete human subject.
Methods: This 58 year old male severely depleted himself of folate, using a folate-deficient diet, until overt
megaloblastic anaemia developed. The biochemical and haematological responses were monitored by routine
blood tests. Daily intake of dietary supplements prevented deficiencies of other relevant nutrients.
Results: The rate of change of all analytes was significantly slower, and the delay before any change for several
analytes was significantly longer, than reported for previous experiments. The time before reporting of abnormal
biochemical and haematological results was therefore very significantly longer than reported by Herbert, but was
consistent with the recent model of Lin et al. Serum folate and red-cell folate became abnormally low after 219
and 413 days respectively. Macrocytic anaemia was produced after 469 days, and megaloblastic anaemia was
confirmed by bone marrow biopsy on day 575. Folate starvation ceased on day 586, and recovery was complete
on day 772.
Conclusions: The currently accepted four month time scale for development of megaloblastic anaemia from
folate deficiency, based on the early work of Herbert and others, is not consistent with the results from this
study. The > 300 day liver folate storage time, predicted by the model of Lin et al., is supported by this
experiment. Self-experimentation has produced a detailed record of the biochemical and haematological
responses to severe experimental folate deficiency, whereas using patients or healthy volunteers as subjects
would be unethical.
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Victor Herbert used self-experimentation to prove that
dietary folate deficiency could cause megaloblastic an-
aemia (Herbert 1962, 1963; Lichtman et al. 2000). From
that study, he developed his hypothesis for the sequen-
tial stages in the development of folate deficiency
(Herbert 1964, 1987a), and recommended dietary folate
intakes (Herbert 1987b). Potassium and iron deficien-
cies, caused by the special diet, confounded the quantita-
tive haematological results (Herbert 1962; Lindenbaum
et al. 1995; Stabler 2009). Other early studies of dietary
folate deficiency culminating in anaemia were per-
formed on healthy volunteers, alcoholics and cancer pa-
tients (Eichner et al. 1971a; Eichner et al. 1971b;
Gailani et al. 1970). All of these early experiments were
restricted, in the range of haematological and biochem-
ical parameters measured, by available technology. For
example, automated cell counters were not yet avail-
able. More recent studies of dietary folate deficiency
have been terminated before the onset of megaloblastic
anaemia (Lindenbaum et al. 1995; Sauberlich et al.
1987; Milne et al. 1983; Kauwell et al. 2000; Jacob et al.
1994; Jacob et al. 1998).
The study of folate kinetics and one-carbon metabol-
ism is important for understanding the role of folate,
and in assessing folate status and preventing folate defi-
ciency (Gregory et al. 2009; Lin et al. 2004; Pietrzik et al.
2007; von der Porten et al. 1992; Gregory and Quinlivan
2002; Gregory et al. 1998; Stites et al. 1997). Biochemical
and haematological response data, from studies of experi-
mental dietary folate deficiency in humans, provides valu-
able inputs into models of folate metabolism (Herbert
1987a; Lindenbaum et al. 1995; Pietrzik et al. 2007).
Gregory et al. (2009) noted the very marked differences
between models.
The findings of Herbert, and others of the pre-folate-
fortification era, suggest that the liver store of folate is
limited to about four months. Herbert (1987b) states:
“Red cell folate reflects liver folate fairly closely ....by a co-
incidence of nature, the red cell life-span is 4 mo and the
liver-folate stores will last for 4 mo.”
Herbert’s hypothesis, supported by his own observa-
tions and those of other researchers of the time, was
widely accepted as the model for the development of fol-
ate deficiency. According to Hoffbrand and Weir (2001):
“Victor Herbert performed the famous experiment in
which he ate a folate-deficient diet for 4 months and
monitored the sequence of events, haematologically and
by assay for folate in blood. He showed that it took about
4 months for megaloblastic anaemia to develop.” Current
advice continues to be based on the findings of the re-
searchers of the pre-folate-fortification era. For example,
Hoffbrand and Provan (2007) state that: “Body stores are
sufficient for only about four months.”A recent model, developed by Lin et al. (2004), pre-
dicts far greater liver folate storage capacity than re-
ported by Herbert. Due to enterohepatic recycling, the
actual size of liver folate storage will significantly affect
the time taken for the onset of folate deficiency follow-
ing commencement of folate deprivation. Lin found that
his model predicted body stores of folate to be nearly
five times greater than previously published and that
these stores would last for hundreds of days when on a
folate-deficient diet.
There have been very few longitudinal studies where
megaloblastic anaemia has been produced, and none
since the commencement of folate fortification of food,
because of ethical concerns regarding risk in human ex-
perimentation when using patients or healthy volunteers
as subjects (Lichtman et al. 2000; Lindenbaum et al.
1995). Self-experimentation has previously been used
successfully in medical research in general (Altman
1998; Weisse 2012), and nutrition research in particular
(Widdowson 1993), to overcome any ethical concerns.
In 2009, while monitoring for a possible secondary
folate deficiency during a self-experiment to investigate
tests for vitamin B12 deficiency, this author discovered
very significant differences between results from three
red-cell folate immunoassay systems. Commencing in
May 2011, this author used himself as the subject of an
experiment to investigate these discrepancies. During
that investigation, described in detail in a separate re-
port (Golding 2014), the biochemical and haemato-
logical responses were recorded.
Objective
The objective of this study was to provide a detailed
record of the biochemical and haematological responses
to the development of severe experimental folate defi-




As a member of COPE (Committee on Publication Eth-
ics), SpringerPlus requires that experiments on human
subjects adhere to the ethical standards of the Declar-
ation of Helsinki. In particular, there must be informed
consent of subjects, and the experiment must be ap-
proved and overseen by a research ethics committee or
institutional review board. Because this author did not
obtain informed consent, and the study did not receive
ethics committee approval, it is necessary for the au-
thor to explain the reasons why publication of this re-
port is ethical.
Firstly, the author was both the experimenter and the
single subject, so the requirement for informed consent
does not apply. There was no institutional involvement,
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assessed by a psychiatrist before the experiment com-
menced, and found to be competent to evaluate the
risks and benefits, and to accept full responsibility for
the conduct of the experiment.
Secondly, the Declaration of Helsinki is silent on self-
experimentation, because it is concerned with the con-
duct of research on patients or healthy volunteers by
others. The requirement for ethics committee approval
therefore does not apply where the single subject is also
the sole experimenter. Also, because there was no insti-
tution involved in the study, with the experiment con-
ducted by an independent researcher, no ethics committee
existed.
Thirdly, the experiment was not performed recklessly
or carelessly; the subject’s condition was monitored
weekly by the psychiatrist. This doctor is a Fellow of the
Royal Australian and New Zealand College of Psychia-
trists, and had no conflict of interests. Being a qualified
medical practitioner receiving all weekly pathology re-
ports, he was able to continually assess the condition of
the subject. For safety, it was agreed at the outset that
he would take control if, but only if, there was an imme-
diate life-threatening condition. The subject instigated,
designed and performed the experiment, and this doc-
tor’s only role was monitoring for safety.
Lastly, the motivation for performing the experiment
was ethical, and involved no conflict of interests. The
author wanted to investigate the gross differences be-
tween the red-cell folate immunoassays, as found during
his experiment of 2009, because he was aware of the po-
tential consequences of errors in measurement of folate
concentrations, especially in pregnant women and others
at high risk of deficiency. The author was motivated only
by the desire to gain and share knowledge, to advance
medical science, for the benefit of patients.Experiment design
A human subject, initially replete in folate, consumed a
folate-deficient diet to severely deplete the body of fol-
ate, culminating in megaloblastic anaemia. Precautions
were taken to avoid the confounding effects of other nu-
trient deficiencies. The biochemical and haematological
responses were monitored by weekly or twice-weekly
blood tests during both the depletion and recovery
stages. Three commercial clinical pathology laborator-
ies, all accredited by the Australian National Associ-
ation of Testing Authorities (NATA), were used to
increase confidence in the results. One research labora-
tory, specializing in microbiological folate assays, was
used to confirm severe folate depletion of the subject.
Megaloblastic anaemia was confirmed by blood cell
counts, blood films, and bone marrow examination.The subject
The subject was this author, a 58 year old male non-
drinker, with no history of folate deficiency or anaemia.
He had for many years consumed a vegetarian diet re-
plete in folate, and had never taken folate supplements.
There are no reported interferences, with any of the ana-
lytes monitored, from any medication taken by the sub-
ject. Because of a history of vitamin B12 deficiency, of
uncertain cause, the subject had been taking 1000 μg
oral methylcobalamin daily for two years immediately
prior to this study. Extensive testing showed consistently
normal results for serum vitamin B12 and the two me-
tabolites, homocysteine and methylmalonic acid, at this
level of intake.The folate-deficient diet
The folate-deficient diet was a modified vegetarian ver-
sion of that used by Herbert (1962, 1963). Several varia-
tions were made during the course of the experiment
to improve the balance between folate reduction and
energy maintenance (Figure 1A and B). This was neces-
sary to minimize the significant weight loss (Figure 1C)
caused by the semi-starvation diet. The average daily
dietary folate intake, during the depletion stage, varied
from 25 μg to 2 μg, or 6% to 0.5% of the recommended
daily intake (RDI) of 400 μg (Institute of Medicine,
National Academy of Sciences 1998). The folate con-
centration for each food item was taken from the data
provided by Food Standards Australia and New Zealand
(2011). For the last ten months of folate starvation, the
diet consisted primarily of white rice, boiled and
washed three times, flavoured with either salt or coco-
nut and sugar; additional energy was supplied by Gator-
ade and barley sugar. Compliance with the diet was
100%.Nutritional precautions
Methionine
Because methionine deficiency could limit the produc-
tion of homocysteine, the subject consumed methionine
supplements (Musashi L–Methionine). This was taken
at a rate of 370 mg per day, from day 77 to day 279, dur-
ing a methionine-deficient variant of the low-folate diet.
The quantity of methionine supplement was calculated
to be half the RDI, of 740 mg/d based on the subject’s
body weight, according to the UN FAO (1991). This
amount was chosen to avoid any “methionine loading”
effect on the homocysteine concentration (Connor et al.
1978). In a healthy subject, with no nutrient deficiency,
homocysteine concentration is not dependent on me-
thionine intake (Ward et al. 2000; Shimakawa et al.





















































Figure 1 Changes in folate and energy intake, and body weight over time. A. Folate intake. B. Energy intake. C. Weight. Severe dietary
folate deficiency commenced on Day 0 (23 May 2011). The folate-replete diet, with folate supplementation, resumed on day 586 (29 December
2012), and recovery was complete on day 772 (3 July 2013). The dotted line in panel A is the recommended daily intake for folate (Institute of
Medicine, National Academy of Sciences 1998). The dotted line in panel B is the initial estimated daily energy requirement for the subject
(Australian Government National Health and Medical Research Council 2013a).
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The subject daily consumed 325 mg ferrous sulphate,
equivalent to 105 mg elemental iron, with 562 mg
sodium ascorbate (Abbott Australia Ferro-Grad C), to
prevent the iron deficiency reported by Herbert (1962).
The sodium ascorbate (vitamin C) is used to assist in
the absorption of the iron. According to the AustralianGovernment National Health and Medical Research
Council (2013b), the iron RDI for men is 8 mg/day.
The subject has no known defect in iron absorption, so
this iron supplement should have ensured adequate
iron status. To check for any deficiency, iron studies
were performed twice during the folate-starvation stage
of the experiment.
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The subject daily consumed 1800 mg slow-release po-
tassium chloride (Novartis Slow-K) to prevent the po-
tassium deficiency reported by Herbert (1962). Serum
potassium concentrations were routinely monitored dur-
ing the experiment.
Vitamins
To avoid vitamin B12 deficiency, the subject continued to
take 1000 μg methylcobalamin daily and, as a precaution
against deficiencies of other B-group vitamins, he also
consumed 62 mg of vitamin B3, and 12 mg of each of vita-
mins B1, B2, and B6 daily.
Blood sampling
Blood sample collection
Precautions were taken to ensure that consistent and valid
blood samples were received by the laboratories. Each of
the three laboratories that performed the routine biochem-
istry and haematology tests collected their own samples,
using professional phlebotomists at government-approved
collection centres. In the morning of each sampling day,
the blood samples were all collected within the narrowest
possible time window; usually not more than two hours
from first to last. The subject always fasted overnight, and
was well hydrated, ensuring maximum possible consistency
between samples. The phlebotomy technique use by each
collector was chosen to provide the highest quality samples;
tourniquet application was carefully controlled, and discard
tubes were used where required. All samples were promptly
transported from the collection centre to the laboratory,
cooled on ice, to avoid deterioration.
Blood sampling frequency
The frequency of routine blood sampling was adapted ac-
cording to the rate of change of the biochemical and haem-
atological responses. Blood samples were initially collected
weekly; this was increased to twice weekly for the last three




All three commercial clinical pathology laboratories were
used to assay red-cell folate, using automated immunoassay
systems. Laboratory A used the Siemens Advia Centaur;
Laboratory B used the Roche Elecsys 2010; Laboratory C
used the Beckman UniCel DxI 800.
Immunoassay serum folate
Laboratories A and B reported serum folate using the
same systems used for red-cell folate; Laboratory C did
not report serum folate.Folate microbiological assays
Microbiological serum and red-cell folate assays, of a
single blood sample collected on day 574, were used to
confirm severe folate depletion of the subject. The assays
were performed by the Food Science and Human Nutri-
tion Department, University of Florida. The procedure,
based on that described by O'Broin and Kelleher (1992),
was developed by the Centers for Disease Control and
Prevention (Zhang et al. 2008).
Special precautions were taken, during collection and
transport of the blood samples, to ensure that valid sam-
ples were received by the laboratory. Serum samples
were collected in serum separator tubes, and whole
blood samples were collected in EDTA tubes. The serum
tubes were spun down at the collection centre, and all
samples were immediately transported, cooled on ice, to
the local laboratory. Aliquots of serum and whole blood
were then transferred to cryovials and frozen to −80°C.
The samples were sent, packed in dry ice, to the labora-
tory in Florida by specialized international courier. All
samples were received frozen, and in excellent condition,
then stored at −80°C until assayed.
Other biochemistry assays
Homocysteine
Serum total homocysteine was routinely assayed by
Laboratory A only, using the Siemens Advia Centaur im-
munoassay system.
Bilirubin and lactate dehydrogenase
Liver functions, including total bilirubin and lactate
dehydrogenase, and electrolytes were assayed by Labora-
tory B using the Roche Cobas Integra 400 Plus.
Iron
Iron studies were performed by Laboratory C, during
the folate-starvation period, on days 420 and 574. Serum
iron, transferrin IBC, transferrin saturation and serum
ferritin were all reported.
Vitamin B12
Vitamin B12 was assayed by Laboratory B, once at the
commencement of the experiment and then four times




Three clinical pathology laboratories, each equipped with
commercially available automated cell counters, were used
to monitor the haematological responses to folate deple-
tion. Laboratories A and C used the Sysmex XE-2100 Au-
tomated Haematology System; Laboratory B used the
Sysmex XS-1000i haematology analyser.
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Two bone marrow biopsies were performed by an expe-
rienced physician, and samples were forwarded to La-
boratory C for examination; the first on day 402; the
second on day 575. Whole blood, bone marrow aspirate
and trephine samples were collected. Marrow aspirate
was examined for cellularity, myelogram was per-
formed, and surface markers analysed. Marrow trephine
was examined for normality of bone trabeculae, cellu-
larity and infiltration.
Recovery diet
The diet used for the recovery stage initially contained
more than 2000 μg folate daily, comprising natural fo-
lates and folic acid fortification (Figure 1A). An add-
itional 400 μg folic acid supplement was taken daily for
the duration of the recovery stage.
Results
Data availability
The data sets supporting all results are included in a
Microsoft Excel spreadsheet file, Additional file 1, con-
taining charts and tables. Details of calculations for the
red-cell lifespan are available, as a Microsoft Excel
spreadsheet, in Additional file 2. High-resolution images
for Figures 1 to 6 are included in a PDF file, Additional file
3, and a Microsoft PowerPoint file, Additional file 4.
Laboratories
The immunoassay red-cell folate results from all three
laboratories have been presented here, because they dif-
fer very significantly. The immunoassay serum folate re-
sults are those from Laboratory A only. Laboratory B
produced similar results, but discontinued reporting
serum folate before the folate depletion stage of the ex-
periment was concluded; Laboratory C did not report
any serum folate results.
The haematology results presented here are from the
primary clinical pathology laboratory, Laboratory A,
only. To improve clarity and, as there were not generally
significant differences between them, the haematology




Serum folate (Figure 2A) was initially above the analyser
limit of 54 nmol/L, a presumed consequence of an initial
folate-replete diet. Serum folate responded without
delay, after commencement of the folate-deficient diet
on Day 0, rapidly falling to a stable level near the normal
lower limit of 6.8 nmol/L in 147 days. There was no
consistent fall below normal until after day 219, when it
fell slowly but consistently to reach zero on day 525.Serum folate increased rapidly immediately after restor-
ation of the normal folate-replete diet.
Immunoassay red-cell folate
The three clinical pathology laboratories reported very sig-
nificantly different results for red-cell folate (Figure 2B).
Results from Laboratory A initially vary randomly around
1000 nmol/L, with no significant response until day 343.
There is then a decelerating fall, to below the normal
lower limit of 360 nmol/L on day 420, reaching zero folate
on day 574. Red-cell folate results from Laboratory B
show an initial concentration of 2988 nmol/L, falling
slowly but without significant delay and with initial severe
instability, reaching a minimum of 879 nmol/L on day
469. Laboratory C shows an initial red-cell folate concen-
tration of 2142 nmol/L, falling slowly but without signifi-
cant delay, with slight instability, reaching a minimum of
535 nmol/L on day 525. All three laboratories reported a
rapid increase in red-cell folate levels immediately follow-
ing resumption of the folate-replete diet.
Folate microbiological assay
The Food Science and Human Nutrition Department,
University of Florida, provided a summary report of
their results for red-cell folate and serum folate (un-
published; copy available from this author) for samples
collected on day 574. The mean serum folate was 0.6 ±
0.09 nmol/L (n = 8), with an inter-assay CV of 5.4% and
an intra-assay CV of 7.9%. The mean red-cell folate was
99 nmol/L, with an inter-assay CV of 12.5% and an
intra-assay CV of 7.2%. The report noted: “We have
never analyzed samples with folate concentrations as
low as these samples.”
Other biochemistry assays
Homocysteine
Serum total homocysteine was initially 9.9 μmol/L,
varying around the recommended upper limit of
10.0 μmol/L, but with no significant change until day
323 (Figure 2D). The homocysteine concentration then
increased exponentially, with some short-term variations,
to reach a maximum of 49.3 μmol/L on day 553. Follow-
ing the resumption of the folate-replete diet, the serum
homocysteine concentration fell rapidly to 7.2 μmol/L.
Bilirubin and lactate dehydrogenase
Total bilirubin and lactate dehydrogenase (LD) were not
monitored until day 295 (Figure 2E and F). Total bilirubin
showed some random short-term variations, below the
normal upper limit of 20 μmol/L until day 518. The biliru-
bin concentration then increased exponentially, to above
the normal range, reaching a maximum of 22 μmol/L on
day 585. LD showed a slow and insignificant fall, from 204







































































































































Figure 2 Changes in biochemistry over time. A. Serum folate. B. Red-cell folate. C. Serum vitamin B12. D. Serum total homocysteine. E. Total
bilirubin. F. Lactate dehydrogenase. The dotted lines in panels A to C are the minimum normals according to Bates and Lewis (2012). The
short-dashed line in panel D is the maximum limit for patients with high coronary risk factors (Stanger et al. 2004), and the long-dashed line
in panel D is the maximum limit in case of normal coronary risk factors (Brouwer et al. 1998). The dashed lines in panels E and F are maximum
normals quoted by the testing laboratory.
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of 230 U/L, reaching a maximum of 252 U/L on day 585.
Total Bilirubin and LD rapidly fell, back into the normal
range, after resumption of the folate-replete diet.
Iron
Results of the two iron studies performed during the
folate-starvation period were all within the normal rangefor the laboratory. Although iron stores were reported as
mildly depleted in the first bone marrow sample col-
lected on day 402, serum iron, transferrin IBC, transfer-
rin saturation and serum ferritin were all reported as
normal 18 days later. All iron studies results were again
reported as normal on day 574, and marrow iron stores
were normal on day 575, 11 days before the end of the
folate-starvation period.
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Serum vitamin B12 remained above the normal lower limit
of 244 pmol/L throughout the experiment (Figure 2C).
There was some variation; 893 pmol/L initially, peaking at
1218 pmol/L on day 301, then falling to a minimum of
659 pmol/L on day 476.
Haematology
Haemoglobin, red-cell count and haematocrit
Haemoglobin, red-cell count and haematocrit were all
within their normal ranges at the commencement of the
experiment (Figure 3A to C). All three analytes initially
responded similarly to folate depletion, without significant
delay, falling slowly until about day 323. Haemoglobin and
haematocrit then remained without significant change
until about day 469. Red-cell count behaved differently,
continuing to fall at a reduced rate, until about day 469.
Haemoglobin, red-cell count and haematocrit all then
fell linearly, to very significantly below the normal
range, reaching minimum levels near day 588, two days
after resumption of the folate-replete diet. They all then
increased without further delay, returning to their ini-
tial levels on day 772.
Mean cell volume, red-cell distribution width and mean cell
haemoglobin
Mean cell volume (MCV), red-cell distribution width
(RDW) and mean cell haemoglobin (MCH) were initially
all within their normal ranges (Figure 3D to F). MCV fell
slightly after commencement the folate deficient diet,
remained steady around 84 fL until day 238, then in-
creased exponentially to a maximum of 116 fL on day
585. Similarly, MCH fell slightly, remained steady around
29 pg until day 301, and then increased exponentially to a
maximum of 41 pg on day 585. RDW behaved differently,
having two distinct peaks at days 343 and 585. MCV,
RDW and MCH all rapidly fell without delay, into their
normal ranges, after resumption of the folate-replete diet.
Reticulocyte count
Reticulocyte count was initially low at 19 × 109/L,
reached a peak of 50 × 109/L on day 308, then fell and
varied between 15 × 109/L and 28 × 109/L until day 588
(Figure 4A). Reticulocyte count rapidly increased to
reach 99 × 109/L on day 590, after resumption of the
folate-replete diet on day 586; there was then a short-
term peak at 106 × 109/L, just above the maximum limit
of the normal range.
Platelets, neutrophils and lymphocytes
The platelet count did not respond to the onset of the
folate-deficient diet, remaining in the normal range until
day 585 (Figure 4B). The neutrophil count was initially
borderline low, at 1.9 × 109/L, decreased slowly to aminimum of 0.9 × 109/L on day 252, then increased
slowly to reach 1.4 × 109/L on day 585 (Figure 4C). After
resumption of the normal folate-replete diet there was a
very rapid response of both platelets and neutrophils;
platelets peaked at 390 × 109/L on day 599, and neutro-
phils peaked at 4.4 × 109/L on day 590. The Lymphocyte
count slowly decreased over the depletion stage, then
remained at borderline-low levels. After a significant
delay, following resumption of the folate-replete diet,
lymphocyte numbers rapidly returned to normal by day
772 (Figure 4D).
Bone marrow examinations
The results of the first bone marrow examination were all
normal except for mildly decreased iron stores, whereas
those for the second clearly demonstrated megaloblastic
anaemia. Cellularity of the aspirate was moderately in-
creased, erythropoiesis showed moderately dyserythro-
poietic features, including megaloblastic changes and poor
hemoglobinization. Some hypersegmented neutrophils
were present but lymphocytes were normal. Plasma cells
were normal and megakaryocytes were within normal
limits; there was an occasional very large form with bi-
zarre nuclear morphology. Iron stores were normal; an oc-
casional ring sideroblast was present. Bone marrow
surface markers were all normal. Trephine biopsy marrow
was hypocellular in one half and normal in the other; tra-
beculae appeared normal. There was no evidence of ma-
lignant infiltration.
The subject
The subject’s weight fell very severely, from 67 kg to
44 kg, during the depletion stage of the experiment
(Figure 1C), and hunger was often severe. He became
extremely tired and weak, with periods of irritability,
confusion, and sleeplessness. Unlike Herbert (1962),
this subject did not experience euphoria on resumption
of the folate-replete diet.
Discussion
The primary finding of this part of the experiment was the
very long time required, from commencement of folate-
starvation, to develop megaloblastic anaemia. The rate of
change of all analytes was significantly slower, and the
delay before any change for several analytes was signifi-
cantly longer, than reported by previously by Herbert and
others (Herbert 1962; Eichner et al. 1971a; Eichner et al.
1971b; Gailani et al. 1970) (Figures 5 and 6). The time be-
fore reporting of abnormal biochemical and haemato-
logical results was therefore very significantly longer than
expected. Both serum and red-cell folate became consist-
ently abnormally low after 219 and 413 days respectively
for this subject, whereas Herbert achieved these low levels
in only 21 and 120 days. Macrocytic anaemia was first
Figure 3 Changes in haematology over time – part 1. A. Haemoglobin. B. Red-cell count. C. Haematocrit. D. Mean cell volume. E. Red-cell
distribution width. F. Mean cell haemoglobin. The dotted lines are the minimum normals, and the long-dashed lines are the maximum normals,
according to Bates Bates and Lewis (2012). The dotted line in panel A is also the WHO haemoglobin level for mild anaemia; the short-dashed line
is the WHO level for moderate anaemia and the dot-dashed line is the WHO level for severe anaemia (World Health Organization 2011).
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126 days for Herbert (1962).
According to Herbert (1964), the time taken to de-
velop a deficiency of red-cell folate, following cessation
of folate intake, is dependent on the lifespan of red
blood cells because folate cannot enter or leave mature
erythrocytes. Also according to Herbert (1964, 1987a),
the lifespan of red blood cells is 120 days, after which all
of the original folate-replete erythrocytes will have been
removed from circulation.There have been several attempts to measure the life-
span of red blood cells in humans (Franco 2009; Furne
et al. 2003; Mitlyng et al. 2006). Recent measurements,
by Furne et al. (2003) using breath carbon monoxide,
gave 122 ± 23 days in 40 healthy volunteers. The lifespan
is affected by chronic disease, often significantly reduced
(Mitlyng et al. 2006), but this author has found no re-
ported cases of greatly extended erythrocyte lifespan.
Laboratories B and C reported red-cell folate falling
from day 0, suggesting a red-cell lifespan of greater than
Figure 4 Changes in haematology over time – part 2. A. Reticulocyte count. B. Platelet count. C. Neutrophil count. D. Lymphocyte count. The
dotted lines are the minimum normals, and the long-dashed lines are the maximum normals, according to Bates and Lewis (2012).
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Furne et al. (2003), the probability of a subject having a
red-cell lifespan longer than 585 days is less than 1 in
1030. Details of this calculation are available, as a Micro-
soft Excel spreadsheet, in Additional file 2. It is therefore
reasonable to exclude an abnormally long red-cell life-
span, for this subject, as an explanation for the unex-
pectedly long time taken to deplete the folate store.
According to Laboratory A, red-cell folate commenced
falling below the baseline concentration after day 343
and reached 0 nmol/L on day 574. Homocysteine and
MCV also commenced increasing above their baseline
concentrations after about day 300. These results suggest
an initial delay of about 300 days, before there is any re-
duction of folate available to the red-cells, followed by
about 230 to 270 days during which the folate was de-
pleted during erythrocyte turnover. Again, based on the
results of Furne et al. (2003), the probability of a subject
having a red-cell lifespan longer than 230 days is about 1
in 106. Although this subject could have had such an ab-
normally long red-cell lifespan, it is not the most likely
explanation for the unexpectedly slow rates of change.
Lin’s model (Lin et al. 2004), showing far greater liver
folate storage capacity than reported by Herbert, offers a
reasonable explanation; the liver folate store can last farlonger than 120 days. By means of enterohepatic recycling,
the red-cell folate level is maintained until the liver stores
are exhausted. This recycling of folate, with a large liver
store, would explain the initial 300 day delay before many
analytes changed significantly from their baseline concen-
trations, as well as the greater than 230 days then required
to totally deplete the red-cell folate.
Herbert (1987a, 1987b) stated that the liver coinciden-
tally stores a four month supply of folate, thus explain-
ing his observation that both red blood cells and the
liver are simultaneously depleted of folate after this time.
Because his experiment was performed in the time be-
fore folate fortification of food, it is likely that Herbert,
and other subjects of his era, had comparatively small
initial liver folate stores. This subject had consumed a
diet replete in folate-fortified food, for many years before
commencement of the experiment, so his liver folate
store is likely to have contained a much larger amount
of folate than Herbert’s.
The practical experimental data presented here, to-
gether with the model of Lin et al. (2004), proves that
Herbert’s assumption that liver storage is limited to
120 days was incorrect. In a truly folate-replete individ-
ual, of the post-fortification era, liver stores can last far
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Figure 6 Comparison of changes in analytes over time. All analytes are shown as a percentage of their maximum value reported for the
duration of the experiment. The folate results used here are from Laboratory A, using the Siemens Advia Centaur.
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Figure 5 Sequence of abnormal events. For quantitative data, the blue bars show the time taken for consistently abnormal results to be
reported. For examination of blood-film slides, the blue bars show the time before the first report of abnormality. The folate results used here are
from Laboratory A, using the Siemens Advia Centaur. The red bars are the results reported by Herbert (1962).
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http://www.springerplus.com/content/3/1/442that the time taken for folate deficiency to occur, from
the commencement of folate starvation, can be much
longer than the 120-day life span of the red cells.
Potential confounding factors - pure folate deficiency
Stabler (2009) refers to the difficulty of obtaining pure fol-
ate deficiency: “Other major causes such as malabsorption
and food deprivation also lead to multiple nutrient defi-
ciencies; thus, it has been difficult to study “pure” cases of
folate deficiency.”
It is not possible, in the real world of practical experi-
mental medicine, to achieve 100% “pure” folate deficiency.
To define such a condition, let alone actually achieve it,
poses many insoluble problems, because it would require:
a perfect ideal model average human subject, with no his-
tory of any medical condition; a fully controlled perfect
environment; a perfect diet with total control over all
nutrients.
Such a condition of “pure” folate deficiency has never
been achieved, and never will be, except in theoretical
models. What is important is to consider the major poten-
tial confounding factors, where possible to avoid them,
and take into account any that cannot be avoided.
This author does not claim to have achieved a 100%
pure model of folate deficiency. The experiment has pro-
duced the first detailed longitudinal study of the devel-
opment of folate deficiency in a human subject since the
folate fortification of food. The introduction of modern
automated cell counters has also provided far more data
than was available to the earlier researchers of Victor
Herbert’s era.
The potential effect of confounding factors also needs to
be considered in the context of the purpose and findings
of the experiment. The primary finding in this study, that
the time taken to achieve megaloblastic anaemia for this
subject was far longer than for previous experiments, was
not affected by any known confounding factor.
Methionine deficiency
The methionine supplements ensured that methionine
deficiency did not confound the results.
The absence of any effect on the homocysteine con-
centration, at the commencement or ceasing of the me-
thionine supplement, together with the expected rapid
increase in homocysteine concentration on depletion of
folate stores, confirms that the potential confounding ef-
fect of methionine deficiency was avoided.
Protein-energy deficiency
Stabler (2009) refers to the potential confounding effect
of protein-energy deficiency: “Protein-calorie malnutri-
tion may cause serious fat atrophy of the bone marrow
and hypoplasia, which could mask megaloblastic changes
observed in folate deficiency.”Liver proteins and creatinine were tested many times
during the experiment. Although proteins and creatinine
were reported as ranging from borderline to low, no fat
atrophy or hypoplasia were reported in either of the
bone marrow examinations of days 402 and 574. The
first marrow examination reported no abnormalities; this
confirms that the low-protein diet did not cause any sig-
nificant confounding effects. The second marrow exam-
ination reported “obvious erythroid hyperplasia”, clearly
demonstrating the effect of folate deficiency.
Iron deficiency
According to Stabler (2009), iron deficiency can con-
found the effect of folate deficiency: “Iron deficiency,
characterized by a reduction in MCV, caused by bleeding
or consumption of an iron-deficient diet that is common
in those with alcoholism, will mask the macrocytosis of
folate deficiency.”
As confirmed by the results of the iron studies, and
the second bone-marrow examination, the iron supple-
ments ensured that there was no iron deficiency. Fur-
thermore, there was no evidence of any confounding
effect of iron deficiency. The subject's mean cell volume
was never below the reference intervals for the three
testing laboratories used, and abnormalities due to iron
deficiency were never reported on their weekly blood
films. In addition, the MCV increased as expected when
folate deficiency progressed.
Vitamin B12 supplements
Although it is well known that large doses of folate can re-
duce the haematological effects of vitamin B12 deficiency,
this author was unable to find any published studies where
vitamin B12 supplements have masked all of the effects of
a primary folate deficiency.
Furthermore, the results show that there was no actual
confounding effect of the vitamin B12 supplementation.
With the vitamin B12 intake constant throughout the ex-
periment, the effects of the folate deficiency can be clearly
observed in the charts for biochemistry and haematology.
For example, the homocysteine ranged from normal to a
very high peak; any significant effect of the vitamin B12
supplement would be expected to suppress this.
Limitations of the experiment
There was only one subject, however such a study can
disprove a currently accepted theory. As stated by Stephen
Hawking (1988): “Any physical theory is always pro-
visional, in the sense that it is only a hypothesis: you can
never prove it. No matter how many times the results of
experiments agree with some theory, you can never be
sure that the next time the result will not contradict the
theory. On the other hand, you can disprove a theory by
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predictions of the theory.”
In the past few decades there has been an increasing
trend towards large trials, involving many subjects, with
numerous authors funded by large institutions. Despite this
move away from small scale research, independent single-
subject experiments can continue to contribute to medical
science. According to Allen B. Weisse (2012), “many
self-experiments have proved invaluable to the medical
community and to the patients we are seeking to help.”
A highly relevant example of a worthwhile single-
subject experiment is the study by the late Victor
Herbert (Herbert 1962), whose work was so significant that
the report was re-published as a landmark haematology
paper of the 20th century (Lichtman et al. 2000). There
are numerous other examples of significant contributions
made to medical science by single-subject experiments
(Altman 1998; Weisse 2012; Widdowson 1993).
For ethical reasons, a study such as this one can only
be performed by means of self-experimentation on a sin-
gle subject. It is therefore not possible to measure the
distribution of times, for development of megaloblastic
anaemia from folate deficiency, in a large group of sub-
jects. What is important is that the primary result of this
experiment, that a single subject had a nineteen month
supply of folate, disproves the currently accepted theory
that the liver store is good for only about four months.
Conclusions
The currently accepted four-month time scale for devel-
opment of megaloblastic anaemia from folate deficiency,
based on the early work of Herbert and others, is not con-
sistent with the results from this study. The > 300 day liver
folate storage time, predicted by the model of Lin et al., is
supported by this experiment. Self-experimentation has
produced a detailed record of the biochemical and haem-
atological responses to severe experimental folate defi-
ciency, whereas using patients or healthy volunteers as
subjects would be unethical.
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